Mallik Kalepu
Family Medicine · Jamaica, NYNPI 1083749303
Payments from drug & device makers
Across 117 payments — averaging $51.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- GSK$1K
- Pfizer$332
- Lilly USA, LLC$308
- Novo Nordisk$295
- Merck$257
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,054100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 14 | $1,677 |
| GSK | 32 | $1,439 |
| Pfizer | 7 | $332 |
| Lilly USA, LLC | 11 | $308 |
| Novo Nordisk | 14 | $295 |
| Merck | 8 | $257 |
| AstraZeneca | 2 | $250 |
| Insmed, Inc. | 2 | $246 |
| Boston Scientific | 2 | $244 |
| Johnson & Johnson | 2 | $172 |
| Amgen | 2 | $133 |
| Mallinckrodt Enterprises LLC | 1 | $125 |
| Bayer | 1 | $118 |
| Exact Sciences | 4 | $99 |
| Intuitive Surgical | 1 | $76 |
| AbbVie | 4 | $60 |
| Mannkind Corporation | 1 | $30 |
| Dexcom, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Shield Therapeutics Inc | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| Global Blood Therapeutics, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Lupin Inc. | 1 | $17 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,054 in reported general payments places this provider in the 90th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 58 | $53,465 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $15,502 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $3,613 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 90 | $3,138 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,818 |
| Novolin NInsulin Nph Human Isophane | 33 | $2,125 |
| Amlodipine Besylate | 399 | $1,303 |
| Insulin Glargine-Yfgn | 14 | $1,258 |
| Atorvastatin Calcium | 174 | $924 |
| Omeprazole | 152 | $905 |
| Metformin Hcl | 176 | $880 |
| Metformin Hcl ErMetformin Hcl | 153 | $779 |
| Lisinopril | 191 | $768 |
| Simvastatin | 139 | $708 |
| Enalapril Maleate | 48 | $674 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet | $257 | $68,96779 claims |
| AstraZenecaSymbicort | $250 | $2,81813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,321 family medicine providers in New York.
Other family medicine in Jamaica
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
- Eric LorraineEndwell$740K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.